John B. Henneman III, Director at Accretive Health, Inc. (ACHI), bought 59,500 shares at $1.78 ($107K) on 2016-08-16, disclosed to the SEC on 2016-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.77 | 500 | $885 | 0.8% |
| 2 | $1.77 | 100 | $177 | 0.2% |
| 3 | $1.78 | 100 | $178 | 0.2% |
| 4 | $1.78 | 500 | $893 | 0.8% |
| 5 | $1.79 | 500 | $895 | 0.8% |
| 6 | $1.80 | 10,000 |
| $18K |
| 16.8% |
| 7 | $1.80 | 10,000 | $18K | 16.8% |
| 8 | $1.80 | 1,500 | $3K | 2.5% |
| 9 | $1.80 | 7,800 | $14K | 13.1% |
| 10 | $1.80 | 12,500 | $23K | 21.0% |
| 11 | $1.81 | 14,500 | $26K | 24.5% |
| 12 | $1.81 | 1,500 | $3K | 2.5% |
| Total | $1.80 avg | 59,500 | $107K | 100% |
| Filing → |
| APRE | BUY | 2024-03-14 | $100K | — | Filing → |
| RCM | SELL | 2023-08-09 | $1.7M | — | Filing → |
| ANIK | BUY | 2021-05-20 | $86K | — | Filing → |